HostTKALSHI vs RIF — price, size and safety, side by side
TKALSHI (Solana) vs RIF (Solana) — every figure is the freshest dated measurement we hold for that token, never a live-feed guess. Prices stamped 2026-09-27 / 2026-09-27.
TKALSHI vs RIF — normalized performance, 2026-09-08 to 2026-09-27T18:22:06
| TKALSHI | RIF | |
|---|---|---|
| Price | $447.17 | $0.0002578 |
| Market cap | $696.67K | $252.54K |
| 24h volume | $302.58K | $4.53K |
| Liquidity | $192.50K | $190.72K |
| FDV | $696.67K | $252.54K |
| Holders | 2,867 | 25,209 |
| Safety grade | A | A |
Where they differ
- TKALSHI measures ~2.8× the market cap of RIF
- TKALSHI measures ~67× the 24h volume of RIF
- RIF measures ~8.8× the holder count of TKALSHI
- over the shared window TKALSHI moved +1.03% while RIF moved +25.1%
What the data says
TKALSHI
TKALSHI — T-Kalshi on Solana, mint TKLSidmLVt3cqGaaodG8tyRzoANfQwoh67AccjmubeZ — is Tessera's tokenized exposure to Kalshi, the regulated prediction-market company. Tessera's site and handle are on the record; the $442.58 unit price across a 1,558-unit supply is share-scaling, not a memecoin. The September 26, 2026 snapshot reads $697 thousand across 2,867 holders.
Kalshi is privately held — like the OpenAI instrument from the same issuer, there is no public float to wrap. What a T-Kalshi unit legally represents lives in Tessera's structure: an SPV interest in secondary-market private shares if it's the real thing, a price-tracking synthetic if it isn't. The chain can verify the market — $192 thousand of liquidity, ~$239 thousand of daily volume — and cannot touch the claim.
RIF
Rifampicin — RIF — the flagship Pump.science longevity token: a DeSci experiment tokenizing a research program on a real compound (the antibiotic rifampicin, a candidate in longevity screening). Mint GJtJuWD9qYcCkrwMBmtY1tpapV1sKfB2zUv9Q4aqpump; the September 26, 2026 snapshot shows about $191 thousand of liquidity and roughly 25,209 holders.
RIF is the honest flagship of DeSci: a real experiment pipeline behind it — fly/worm longevity studies whose results stream publicly — which is a real thing, but the honest gap is that token price tracks narrative attention on the research, not a claim on any resulting IP or drug. If rifampicin's data disappoints, the token has no floor.
FAQ
Which is bigger, TKALSHI or RIF?
By tracked market cap: TKALSHI (Solana) measures $696.67K and RIF (Solana) measures $252.54K — dated snapshots, not a live feed.
Which is safer, TKALSHI or RIF?
On the contract checks we publish: TKALSHI (Solana) grades A and RIF (Solana) grades A. A grade is a structural check on the contract, not a promise about the asset.
How have TKALSHI and RIF performed over the shared window?
Between 2026-09-08 and 2026-09-27T18:22:06, the measured snapshots show TKALSHI at +1.03% and RIF at +25.1%.
More comparisons
ME vs TKALSHIAPE vs TKALSHITTWO vs TKALSHITKALSHI vs SOLRIF vs SOLRIF vs UNIRIF vs BODENRIF vs NST
The grade column is the one CMC's compare page cannot print — our grade is computed from the contract itself (mint/freeze authority, liquidity, holder concentration). Changes are measured over the shared window stated on the chart, 2026-09-08→2026-09-27T18:22:06; a token with fewer measured points measures a shorter span inside it.
Figures are dated on-chain snapshots, not a live feed. Safety grades are structural checks — not investment advice. Free · no signup · a NexFlow product.